Beam Therapeutics’ year-to-date stock performance.
Beam Therapeutics: “We don’t want to buy any stocks that are heavily shorted because they are all by nature heavily shorted because they don’t have any earnings. I would buy this if you thought that they’ve got something that can save a lot of lives. That’s it. Otherwise move on.”
Ondas’ year-to-date stock performance.
Ondas: “It’s a company that is losing a lot of money, that does intelligent or autonomous systems, like every other company. I’d rather have to find something new and different that is distinct. And I don’t see anything distinct about Ondas.”
Halliburton’s year-to-date stock performance.
Halliburton: “I like Halliburton very much. I think that it’s been a good stock even in a bad oil market, so it’s been a great stock in a good oil market, and I continue to think it’s very inexpensive.”
Snap’s year-to-date stock performance.
Snap: “I’m a growth buyer, and this company does not have growth, and that’s why the stock has been so awful.”
Nokia’s year-to-date stock performance.
Nokia: “I think it’s a winner. It’s back. I can’t believe it. It finally did come back, and I got to hand it to those guys for sticking around because, wow, I think it’s got a lot of good technology.”
Cameco Corporation’s year-to-date stock performance.
Cameco Corporation: “I like CCJ because it’s a real uranium company. It’s not a mock uranium company that a lot of the people come up with. You’ve got a winner in CCJ.”
Novo Nordisk’s year-to-date stock performance.
Novo Nordisk: “I don’t want your own Novo Nordisk either, though. I think that they are not good at what they do. What I would do if you want to stick in that business is I would go buy some J&J.”
Harley-Davidson’s year-to-date stock performance.
Harley-Davidson: “The technology is absolutely terrific, but the actual earnings, they’re just blah. I can’t go for it. I can’t recommend a non-growth stock on this show”
